Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | IDE | P14735 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | BCHE | P06276 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6522028 | 1.00 | PPARG (0.36) | PPARGMAPTMEN1KMT2AUSP2 | |
| SCHEMBL6522033 | 1.00 | PPARG (0.36) | PPARGMAPTMEN1KMT2AUSP2 | |
| SCHEMBL13646918 | 0.84 | PPARG (0.34) | PPARGMAPTMEN1KMT2AUSP2 | |
| SCHEMBL11460156 | 0.84 | BCHE (0.34) | PPARGMAPTMEN1KMT2AUSP2 | |
| SCHEMBL28863165 | 0.83 | ALDH1A1 (0.35) | PPARGMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL28250648 | 0.81 | ALDH1A1 (0.38) | PPARGMAPTMEN1KMT2AUSP2 | |
| SCHEMBL6426503 | 0.77 | MAPT (0.54) | MAPTMEN1KMT2AUSP2IDE | |
| SCHEMBL21126650 | 0.76 | MAPT (0.34) | PPARGMAPTMEN1KMT2AUSP2 | |
| Iodide SCHEMBL31607475 | 0.76 | MAPT (0.53) | MAPTMEN1KMT2AUSP2IDE | |
| SCHEMBL20717990 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101512009-B | Array for rapid detection of microorganisms | KIMBERLY CLARK CO | 2014-09-24 | — | — | CN | disclosed |
| CN-101784896-A | The rapid evaluation of upper respiratory conditions | KIMBERLY CLARK CO | 2010-07-21 | — | — | CN | disclosed |
| CN-101512009-A | Array for rapid detection of microorganisms | KIMBERLY CLARK CO (US) | 2009-08-19 | — | — | CN | disclosed |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | VERVA PHARMACEUTICALS PTY LTD (AU) | 2005-12-22 | — | — | US | disclosed |
| CN-1173954-C | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | 3 | 2004-11-03 | — | — | CN | disclosed |
| CN-1312252-A | Intermediate of chemical compound generating chemical illumination when reacts with phosphatase | RUMIGEN CO (US) | 2001-09-12 | — | — | CN | disclosed |
| CN-1180349-A | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | LUMIGEN INC (US) | 1998-04-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | FGF1, FABP4, FGF2 | PPARG 25/4885MAPT 4367/4885MEN1 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.